Tendai Chisowa | Substack

Tendai Chisowa

•

Tendai is an early stage biotech investor at Hummingbird Ventures. She completed her PhD at the University of Cambridge, engineering proteomic tools to study the dynamics of leptin signaling in the hypothalamus.

983 subscribers

BioVizion

By Tendai Chisowa

Featuring summaries of exciting scientific publications along with commercial implications.

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts